Company Filing History:
Years Active: 2023
Title: **Innovator Spotlight: Sunghou Lee**
Introduction
Sunghou Lee is an accomplished inventor based in Yongin-si, South Korea, known for his significant contributions to the field of biotechnology. With a focus on protein transduction, Lee has developed innovative solutions that enhance the delivery of therapeutic agents into cells and tissues.
Latest Patents
Sunghou Lee holds a patent for a "Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compound." This invention introduces a protein transduction domain and fusion compound that demonstrate enhanced efficacy. Through rigorous testing of various candidate peptides, Lee and his team discovered that a GK1 peptide, consisting of 18 amino acids, can effectively bond with high-molecular-weight materials like proteins. This breakthrough allows these materials to penetrate living organisms—such as cells, tissues, or blood—more smoothly. Furthermore, the fusion compound, oligonucleotide, or vector derived from this research holds great promise as a pharmaceutical composition for the prevention and treatment of diseases.
Career Highlights
Lee is associated with Genesen Co., Ltd., a company that presumably focuses on developing innovative biopharmaceutical solutions. His work has led to substantial advancements in how therapeutic drugs are delivered, potentially transforming treatment approaches for various medical conditions.
Collaborations
Throughout his career, Sunghou Lee has collaborated with notable colleagues, including Soo-Young Choi and Jin-Seu Park. Together, they have furthered research in the field and contributed to the impactful innovations that have emerged from their collective expertise.
Conclusion
Sunghou Lee exemplifies the spirit of innovation and advancement in biotechnology. His work not only showcases his inventive capabilities but also holds the potential for significant medical breakthroughs in drug delivery systems. As he continues to develop and refine his inventions, Lee remains a prominent figure in the world of biopharmaceutical research and development.